FASLG and systemic lupus erythematosus: When APS and SLE patients were further stratified according to clinical phenotype and aPL status, we observed that APCr with both the ST Genesia and the CAT using Protac®, but not with the CAT using rhAPC, was significantly greater in triple aPL APS patients compared to double/single aPL patients and in thrombotic SLE patients compared to non-thrombotic SLE patients.